Geode Capital Management, LLC Caladrius Biosciences, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.41 - $0.74 $3,471 - $6,265	8,467 Added 2.22%	390,625 $207,000
Q3 2021 Nov 12, 2021	BUY	$1.15 - $1.57 $11,072 - $15,115	9,628 Added 2.58%	382,158 $466,000
Q2 2021 Aug 13, 2021	BUY	$1.4 - $1.9 $76,127 - $103,316	54,377 Added 17.09%	372,530 $599,000
Q1 2021 May 12, 2021	BUY	$1.44 - $2.89 $391,125 - $784,967	271,615 Added 583.64%	318,153 $614,000
Q2 2018 Aug 14, 2018	BUY	$3.8 - $8.64 $74,594 - $169,603	19,630 Added 72.95%	46,538 $301,000

Q4 2017 Feb 13, 2018	SELL	$2.66 - $3.71 $5,548 - $7,739	-2,086 Reduced 7.19%	26,908 $94,000
Q2 2017 Aug 14, 2017	BUY	N/A	28,994	28,994 $134,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.